THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

The company stated that although it has dropped vobra duo, it remains optimistic about its other candidate MGC026.

LUND, SWEDEN / ACCESS Newswire / March 21, 2025 / Alligator Bioscience (Nasdaq Stockholm:ATORX) today announces that Dr. Sumeet Ambarkhane MD, Chief Medical Officer, will be leaving Alligator by end o ...

Shares of Elevation Oncology ELEV plunged more than 40% yesterday after reporting disappointing data from a phase I study on ...

The label expansion couls help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...